| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 8.9% | $13,333,411 | 4,232,829 | Invus Public Equities, L.P. | 31 Dec 2023 | |||
| BAILLIE GIFFORD & CO | 4.1% | $6,046,960 | 1,919,670 | BAILLIE GIFFORD & CO | 31 Dec 2024 |
As of 30 Sep 2025, 11 institutional investors reported holding 5,644,984 shares of Nanobiotix S.A. - Common Stock (NBTX). This represents 12% of the company’s total 46,821,220 outstanding shares.
The largest institutional shareholders of Nanobiotix S.A. - Common Stock (NBTX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 12% | 5,623,816 | 0% | 21% | $106,233,884 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.02% | 10,184 | 0% | 0% | $192,375 |
| Optiver Holding B.V. | 0.01% | 5,356 | 0% | $101,175 | |
| MORGAN STANLEY | 0.01% | 2,378 | -55% | 0% | $44,920 |
| UBS Group AG | 0% | 2,161 | -51% | 0% | $40,821 |
| EverSource Wealth Advisors, LLC | 0% | 514 | -0.58% | 0% | $9,709 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 400 | 0% | 0% | $7,556 |
| ROYAL BANK OF CANADA | 0% | 125 | 0% | 0% | $2,000 |
| RHUMBLINE ADVISERS | 0% | 33 | 0% | 0% | $623 |
| NATIONAL BANK OF CANADA /FI/ | 0% | 13 | 0% | 0% | $245 |
| BARCLAYS PLC | 0% | 4 | 0% | $76 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 229 | $5,294 | +$5,294 | $23.12 | 1 |
| 2025 Q3 | 5,644,984 | $106,633,384 | +$3,363 | $18.89 | 11 |
| 2025 Q2 | 5,645,167 | $25,555,914 | -$413,807 | $4.73 | 9 |
| 2025 Q1 | 5,761,181 | $20,624,582 | -$1,004,115 | $3.58 | 10 |
| 2024 Q4 | 6,067,225 | $17,419,035 | -$1,000,405 | $2.87 | 16 |
| 2024 Q3 | 6,417,922 | $36,903,052 | -$14,323,739 | $5.75 | 9 |
| 2024 Q2 | 9,293,451 | $46,466,940 | -$68,645 | $5.00 | 11 |
| 2024 Q1 | 9,306,982 | $59,748,622 | +$232,249 | $6.50 | 11 |
| 2023 Q4 | 9,271,406 | $67,496,071 | +$33,488,953 | $7.28 | 12 |
| 2023 Q3 | 4,468,338 | $39,097,959 | +$8,789,679 | $8.75 | 9 |
| 2023 Q2 | 3,463,804 | $17,715,486 | +$5,090 | $5.07 | 5 |
| 2023 Q1 | 3,462,800 | $12,353,370 | -$3,852 | $3.52 | 4 |
| 2022 Q4 | 3,463,881 | $12,194,444 | +$2,929 | $3.67 | 5 |
| 2022 Q3 | 3,463,083 | $12,218,000 | -$49,000 | $3.54 | 5 |
| 2022 Q2 | 3,476,092 | $13,278,000 | -$18,904 | $3.78 | 6 |
| 2022 Q1 | 3,481,131 | $25,974,000 | -$293,545 | $7.25 | 6 |
| 2021 Q4 | 3,520,885 | $28,772,000 | -$6,268,938 | $8.10 | 7 |
| 2021 Q3 | 4,094,109 | $46,466,000 | -$10,429,241 | $11.36 | 9 |
| 2021 Q2 | 4,852,401 | $66,866,000 | -$203,430 | $13.78 | 10 |
| 2021 Q1 | 4,867,161 | $73,173,000 | -$987,346 | $15.04 | 10 |
| 2020 Q4 | 3,926,653 | $64,791,000 | +$64,791,001 | $16.50 | 10 |